Shurygina AP - Search Results

1

SARS-CoV-2 escape from cytotoxic T cells during long-term COVID-19.

Stanevich OV, Alekseeva EI, Sergeeva M, Fadeev AV, Komissarova KS, Ivanova AA, Simakova TS, Vasilyev KA, Shurygina AP, Stukova MA, Safina KR, Nabieva ER, Garushyants SK, Klink GV, Bakin EA, Zabutova JV, Kholodnaia AN, Lukina OV, Skorokhod IA, Ryabchikova VV, Medvedeva NV, Lioznov DA, Danilenko DM, Chudakov DM, Komissarov AB, Bazykin GA. Stanevich OV, et al. Among authors: shurygina ap. Nat Commun. 2023 Jan 10;14(1):149. doi: 10.1038/s41467-022-34033-x. Nat Commun. 2023. PMID: 36627290 Free PMC article.

2

Preclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccine.

Romanova J, Krenn BM, Wolschek M, Ferko B, Romanovskaja-Romanko E, Morokutti A, Shurygina AP, Nakowitsch S, Ruthsatz T, Kiefmann B, König U, Bergmann M, Sachet M, Balasingam S, Mann A, Oxford J, Slais M, Kiselev O, Muster T, Egorov A. Romanova J, et al. Among authors: shurygina ap. PLoS One. 2009 Jun 19;4(6):e5984. doi: 10.1371/journal.pone.0005984. PLoS One. 2009. PMID: 19543385 Free PMC article.

3

Influenza B mutant viruses with truncated NS1 proteins grow efficiently in Vero cells and are immunogenic in mice.

Wressnigg N, Shurygina AP, Wolff T, Redlberger-Fritz M, Popow-Kraupp T, Muster T, Egorov A, Kittel C. Wressnigg N, et al. Among authors: shurygina ap. J Gen Virol. 2009 Feb;90(Pt 2):366-374. doi: 10.1099/vir.0.006122-0. J Gen Virol. 2009. PMID: 19141445

4

A genetically adjuvanted influenza B virus vector increases immunogenicity and protective efficacy in mice.

Kittel C, Wressnigg N, Shurygina AP, Wolschek M, Stukova M, Romanovskaya-Romanko E, Romanova J, Kiselev O, Muster T, Egorov A. Kittel C, et al. Among authors: shurygina ap. Arch Virol. 2015 Oct;160(10):2525-34. doi: 10.1007/s00705-015-2525-9. Epub 2015 Jul 28. Arch Virol. 2015. PMID: 26215439

5

Intranasal Immunization with the Influenza A Virus Encoding Truncated NS1 Protein Protects Mice from Heterologous Challenge by Restraining the Inflammatory Response in the Lungs.

Vasilyev K, Shurygina AP, Sergeeva M, Stukova M, Egorov A. Vasilyev K, et al. Among authors: shurygina ap. Microorganisms. 2021 Mar 26;9(4):690. doi: 10.3390/microorganisms9040690. Microorganisms. 2021. PMID: 33810549 Free PMC article.

6

Enhancement of the Local CD8⁺ T-Cellular Immune Response to Mycobacterium tuberculosis in BCG-Primed Mice after Intranasal Administration of Influenza Vector Vaccine Carrying TB10.4 and HspX Antigens.

Vasilyev K, Shurygina AP, Zabolotnykh N, Sergeeva M, Romanovskaya-Romanko E, Pulkina A, Buzitskaya J, Dogonadze MZ, Vinogradova TI, Stukova MA. Vasilyev K, et al. Among authors: shurygina ap. Vaccines (Basel). 2021 Nov 3;9(11):1273. doi: 10.3390/vaccines9111273. Vaccines (Basel). 2021. PMID: 34835204 Free PMC article.

7

A New Intranasal Influenza Vector-Based Vaccine TB/FLU-04L Against Tuberculosis: Preclinical Safety Studies.

Buzitskaya Z, Stosman K, Khairullin B, Kassenov M, Nurpeisova A, Abylai Sansyzbay A, Shurygina AP, Aleksandrov A, Sivak K, Stukova M. Buzitskaya Z, et al. Among authors: shurygina ap. Drug Res (Stuttg). 2022 Jun;72(5):255-258. doi: 10.1055/a-1785-3936. Epub 2022 Mar 22. Drug Res (Stuttg). 2022. PMID: 35318622

8

Preclinical Evaluation of TB/FLU-04L-An Intranasal Influenza Vector-Based Boost Vaccine against Tuberculosis.

Shurygina AP, Zabolotnykh N, Vinogradova T, Khairullin B, Kassenov M, Nurpeisova A, Sarsenbayeva G, Sansyzbay A, Vasilyev K, Buzitskaya J, Egorov A, Stukova M. Shurygina AP, et al. Int J Mol Sci. 2023 Apr 18;24(8):7439. doi: 10.3390/ijms24087439. Int J Mol Sci. 2023. PMID: 37108602 Free PMC article.

9

IgGκ Signal Peptide Enhances the Efficacy of an Influenza Vector Vaccine against Respiratory Syncytial Virus Infection in Mice.

Pulkina A, Vasilyev K, Muzhikyan A, Sergeeva M, Romanovskaya-Romanko E, Shurygina AP, Shuklina M, Vasin A, Stukova M, Egorov A. Pulkina A, et al. Among authors: shurygina ap. Int J Mol Sci. 2023 Jul 14;24(14):11445. doi: 10.3390/ijms241411445. Int J Mol Sci. 2023. PMID: 37511205 Free PMC article.

10

Adaptive mutation in nuclear export protein allows stable transgene expression in a chimaeric influenza A virus vector.

Kuznetsova I, Shurygina AP, Wolf B, Wolschek M, Enzmann F, Sansyzbay A, Khairullin B, Sandybayev N, Stukova M, Kiselev O, Egorov A, Bergmann M. Kuznetsova I, et al. Among authors: shurygina ap. J Gen Virol. 2014 Feb;95(Pt 2):337-349. doi: 10.1099/vir.0.056036-0. Epub 2013 Nov 12. J Gen Virol. 2014. PMID: 24222196

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters